Monoclonal Rat Antibody Against Ki67
The monoclonal rat antibody against Ki67 developed by HistoSure only recognizes mouse Ki67 and shows no cross-reactivity against human Ki67.
Read more
monoclonal antibodies
Lilly to supply 300,000 vials of COVID-19 monoclonal antibody to the U.S.
Eli Lilly and Company officially announced on Oct. 28, an initial deal with the U.S. government to supply 300,000 vials
Read more
Lilly’s Mirikizumab shows reduction of Intestinal Inflammation in Crohn’s Disease
Eli Lilly and Company revealed on Monday, new efficiency and safety results from the Phase 2 SERENITY trial assessing Mirikizumab
Read more
Enzolytics and BioClonetics intent to merge sends stock parabolic
Enzolytics, Inc, a drug development company with a focus on debilitating infectious diseases, announced on September 16, the execution of
Read more
Donald Trump treated with experimental Monoclonal Antibody cocktail
United States President Donald Trump has been administered with an intravenous dose of Regeneron Pharmaceuticals experimental COVID-19 treatment REGN-COV2, a
Read more
Janssen’s Golimumab gets FDA nod for pediatric use in Juvenile Arthritis
Janssen’s Golimumab, a human monoclonal antibody used as an immunosuppressive drug and sold under the brand name Simponi, has received
Read more
New analysis proposes Severe COVID-19 is a Microvascular Disease
The range of clinical responses to SARS-CoV-2 infection is extremely broad, a factor making the disease particularly difficult to properly
Read more
New data reveals Roche’s OCREVUS is highly effective for RRMS
Swiss pharma giant Roche announced today new data that demonstrates OCREVUS® (ocrelizumab) is a highly effective treatment option for people
Read more
Lilly starts Phase 3 Trial of monoclonal antibody for COVID-19 prevention
Eli Lilly and Company announced the start of BLAZE-2, a Phase 3 study of the monoclonal antibody LY-CoV555 vaccine candidate
Read more
Merck to licence two preclinical immuno oncology programs from F-star
Two additional preclinical discovery programs will be added to the Merck KGaA and F-star Therapeutics collaboration. Merck KGaA, Darmstadt, Germany
Read more